Bradley J. Monk
布拉德利·蒙克
MD, FACS, FACOG
Professor and Director of Gynecologic Oncology妇科肿瘤学教授兼主任
👥Biography 个人简介
Dr. Bradley Monk is a globally recognized gynecologic oncologist at University of Arizona/HonorHealth, known for leading pivotal clinical trials in ovarian and cervical cancer. He has driven adoption of PARP inhibitors and anti-angiogenic therapies in gynecologic malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
PARP Inhibitor Trials
Led landmark trials establishing niraparib and olaparib maintenance therapy in ovarian cancer, transforming standard of care for BRCA-mutated and HRD-positive patients.
Cervical Cancer Immunotherapy
Principal investigator on trials combining bevacizumab and checkpoint inhibitors in advanced cervical cancer, improving survival outcomes in recurrent disease.
Representative Works 代表性著作
Niraparib Maintenance Therapy in Platinum-Sensitive Ovarian Cancer
New England Journal of Medicine (2016)
Established niraparib as effective maintenance therapy regardless of BRCA mutation status in platinum-sensitive ovarian cancer.
Bevacizumab in Cervical Cancer (GOG 240)
New England Journal of Medicine (2014)
Demonstrated survival benefit of adding bevacizumab to chemotherapy in recurrent/metastatic cervical cancer.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Kathleen N. Moore
Stephenson Cancer Center, University of Oklahoma
Ana Oaknin
Vall d'Hebron University Hospital
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center
Vicky Makker
Memorial Sloan Kettering Cancer Center
关注 布拉德利·蒙克 的研究动态
Follow Bradley J. Monk's research updates
留下邮箱，当我们发布与 Bradley J. Monk（University of Arizona / HonorHealth）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment